02.04.2020

Sport Pharmacology

YK11

YK11 guide: is it a SARM or steroid? How it works via myostatin inhibition, dosage (5-12mg), suppression, and stacking protocols for mass and strength.

YK11 is a research compound that exists in a unique gray area between SARMs and anabolic steroids. A lack of in-vivo (animal or human) studies makes its full effects and safety profile largely speculative. It is primarily of interest due to its proposed mechanism of increasing follistatin, a protein that inhibits myostatin—a key regulator that limits muscle growth.

What is YK11: SARM or Steroid

Chemically, YK11 possesses a steroidal backbone, which differentiates it from traditional non-steroidal SARMs like Ostarine or Ligandrol. This structural similarity to steroids has led many to classify it as a steroidal SARM or a designer anabolic steroid.

Its primary mechanism, according to limited in-vitro studies, is acting as a partial agonist of the androgen receptor while significantly upregulating follistatin. By inhibiting myostatin, it may promote muscle growth through a pathway that is independent of, and potentially synergistic with, traditional androgen receptor activation.

Proposed Benefits and Mechanism

Myostatin Inhibition: Its most touted potential benefit is increasing follistatin levels, which blocks myostatin. This could theoretically lead to muscle growth beyond normal genetic limits.
Androgenic Activity: As a partial AR agonist, it may provide direct anabolic stimulation, though this is believed to be weaker than pure androgens like testosterone.
Potential Anti-Androgenic Effect: A significant theoretical downside is that as a partial agonist, YK11 may compete with and block stronger androgens (like testosterone or DHT) at the receptor site, potentially reducing their effectiveness if used concurrently.

Dosage, Administration, and Suppression

Due to the absence of clinical data, dosing is based entirely on anecdotal user reports.

Common Dosage Range: 5 mg to 12 mg per day.
Administration: Split into 2-3 doses daily due to a presumed short half-life. It is typically taken orally.
Hepatotoxicity Concern: Its chemical structure suggests potential liver stress. Liver support supplements (e.g., TUDCA, NAC) are strongly advised.
Suppression: Anecdotal evidence and its steroidal nature indicate it is suppressive to natural testosterone production, requiring Post-Cycle Therapy (PCT).

YK11 Stacks and Cycles

Given its unique mechanism, YK11 is often stacked to capitalize on myostatin inhibition while ensuring strong androgenic stimulation.

Stack Name	Primary Goal	Key Compounds	Dosage & Cycle Guidelines
Myostatin Inhibition Stack	Maximize muscle growth via dual pathways.	1. YK11 2. Testosterone (Base) 3. LGD-4033 (Ligandrol)	1. YK11: 10mg/day (Weeks 1-8). 2. Test E/C: 300-500mg/week (Weeks 1-12). 3. LGD: 10mg/day (Weeks 1-8). Requires full PCT.
Strength & Density Focus	Increase strength and muscle density with minimal water.	1. YK11 2. RAD-140 (Testolone) 3. S4 (Andarine)	1. YK11: 8mg/day (Weeks 1-8). 2. RAD-140: 20mg/day (Weeks 1-8). 3. S4: 50mg/day (Weeks 1-8). Requires SERM PCT.
Cutting & Recomposition	Build lean mass, enhance hardness while losing fat.	1. YK11 2. Ostarine (Mk-2866) 3. Cardarine (GW501516)	1. YK11: 5-7mg/day (Weeks 1-6). 2. Ostarine: 25mg/day (Weeks 1-8). 3. Cardarine: 20mg/day (Weeks 1-8). PCT required for YK11/Ostarine.

Cardarine - GW501516 (Fat Loss) 10mg/50tabs - NEO Sarms

Cardarine is the best SARM for weight loss and fat burning. It can be combined with any other SARM, peptide, or steroid agent for a more potent effect. Perfect anabolic agent for female bodybuilders. Usage: 10-20 mg/day Cycle

$90.00

Andarine - S4 (Muscle Mass) 10mg/50tabs - NEO Sarms

Andarine is not as potent as some other SARMs in terms of muscle gain, but it is a great solution to increase strength and endurance, burn fat, increase testosterone levels, improve bones' density and muscle definition & hardness. Less potent

$70.00

Ostarine - MK2866 (Muscle Mass/Fat Loss) 10mg/50tabs - NEO Sarms

This SARM significantly improves muscle mass & physical performance, increases bone strength, and boosts collagen metabolism. Will preserve muscle tissue and stimulate recovery & endurance Usage: 20-30 mg/day Cycle

$75.00

Post-Cycle Therapy (PCT)

YK11 is suppressive. A standard PCT is necessary to restore natural hormone function after a cycle.

Begin PCT 2-3 days after the last YK11 dose.

Weeks 1-2: Tamoxifen (Nolvadex) 20mg/day, Clomid (Clomiphene) 25mg/day.
Weeks 3-4: Tamoxifen 10mg/day, Clomid 12.5mg/day.

Conclusion

YK11 is a potent but poorly understood research compound. Its theoretical ability to inhibit myostatin is compelling, but this is balanced by significant unknowns regarding its long-term safety, potential hepatotoxicity, and possible anti-androgenic effects when stacked. It should be approached with extreme caution, strictly for research purposes by experienced users who understand the risks. Comprehensive pre, mid, and post-cycle bloodwork (including liver enzymes and lipids) is non-negotiable. Given the lack of data, it cannot be recommended over established, better-studied compounds.